Home » Newsletters » BioWorld Science

BioWorld Science

June 23, 2008

View Archived Issues

Vx-001 telomerase vaccine immunogenic in advanced solid tumor patients

Proof-of-concept trial shows potential of atiprimod in neuroendocrine carcinoma

Data on activity of XL-647 in non-small cell lung cancer accumulates

Favorable phase III results with odanacatib in postmenopausal osteoporosis

Novel antipsoriatic agents imparted in recent University of Sunderland patent

Metabasis reports positive results from phase Ib clinical trial of MB-07811

Theratechnologies reports positive results from phase III clinical trial of tesamorelin

Aplindin effective alone and in combination with dexamethasone

Bavarian reports interim data from two phase I/II studies of MVA-BN-HER2

Euro Nippon Kayaku withdraws its MAA for Spanidin

Recent patents describe novel therapeutic agents for respiratory disorders

FDA lifts clinical hold on AeroLEF and clears phase II clinical trial

FDA approves Avodart in combination with tamsulosin for enlarged prostate

CureVac enters partnership with University of Florida to develop CV-9103 in prostate cancer

Forest announces results from CANVAS I and CANVAS II phase III studies of ceftaroline

First phase II study results of CK-1827452 in patients with heart failure

Merck provides update on U.S. regulatory status for MK-0524A and MK-0524B

Avontec reports results from a phase I study of AVT-02 UE for inflammatory skin diseases

NeuroSearch reports positive results from a phase II study in adult ADHD

Pharmaxis and the FDA agree on SPA for Bronchitol phase III registration trial

Phase II trial evaluates Reolysin in combination with paclitaxel and carboplatin

Welichem Biotech completes phase IIa WBI-1001 clinical trial in atopic dermatitis

FDA approves Velcade for injection in patients with multiple myeloma

Astellas submits sNDA in Japan for Prograf in ulcerative colitis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 3, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...